Featured Posts

Wednesday, April 3, 2019

FDA continues to enforce CBD claims language as meeting on botanical is set for May

FDA has sent three companies marketing CBD products warning letters over disease claims. The warnings are the first issued under FDAâs de facto âenforcement discretionâ policy, which will be discussed at a meeting on CBD set for the end of May.

from NutraIngredients-USA RSS http://bit.ly/2OGia8P

No comments:

Post a Comment